Rating History for Dicerna Pharmaceuticals (DRNA) by Chardan

More Stocks Rated by Chardan | Latest Ratings for DRNA
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/9/2021 Keay Nakae Downgrade Neutral
(Buy)		 38.25
(N/A)		 38.16
(38.22)		 0.16% Details